These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24931573)

  • 1. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
    Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
    Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
    Fullmer A; McCue D; Feng C
    J Oncol Pharm Pract; 2014 Dec; 20(6):403-8. PubMed ID: 24177356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
    Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ; Shankar V
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
    Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
    Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
    Wong-Beringer A; Joo J; Tse E; Beringer P
    Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
    McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
    J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
    Prabaker KK; Tran TP; Pratummas T; Goetz MB; Graber CJ
    J Hosp Med; 2012 Feb; 7(2):91-7. PubMed ID: 22086511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
    Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
    J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury during vancomycin therapy in critically ill children.
    Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
    Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
    Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity.
    Choi YC; Saw S; Soliman D; Bingham AL; Pontiggia L; Hunter K; Chuang L; Siemianowski LA; Ereshefsky B; Hollands JM
    Ann Pharmacother; 2017 Nov; 51(11):937-944. PubMed ID: 28709394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.